Gjør som tusenvis av andre bokelskere
Abonner på vårt nyhetsbrev og få rabatter og inspirasjon til din neste leseopplevelse.
Ved å abonnere godtar du vår personvernerklæring.Du kan når som helst melde deg av våre nyhetsbrev.
This volume details methods and protocols covering multiple aspects of Medulloblastoma. Divided into four parts, chapters guide readers through nucleic acids detection and analysis, cell-based analysis methodologies, and applications of patient-information on designing better experimental strategies for future drug development efforts in Medulloblastoma. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and cutting-edge, Medulloblastoma: Methods and Protocols aims to deliver a clear-cut and standardized set of protocols to a broad scientific community.
Biopatents are patents pertaining to life forms excluding microorganisms. This field of patent is in a very nascent stage whereby a stiff conflict goes on between developed and developing countries. Biopatents are a means to develop disease resistant varieties of plants, animals and genetic improvement of human beings whereby strong progenies may be born in future. The TRIPS agreement has provided for a balancing approach whereby the developing countries are given freedom to incorporate the terms of the agreement in their laws within definite time frame. The book casts a balancing approach protecting the rights of both author and public so that the hard earned money and labour of the inventor does not go in vain and much more health benefits can be availed while balancing biopatents with ethics, human rights and ownership issues making biopatents an epitome of success.
Abonner på vårt nyhetsbrev og få rabatter og inspirasjon til din neste leseopplevelse.
Ved å abonnere godtar du vår personvernerklæring.